Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #179178 on Biotech Values
DewDiligence
06/12/14 9:38 AM
#179184 RE: frontiers #179178
ACHN—If you have bothered to review the preclinical data for [ACH-3422] compared to sofosbuvir, you will see that 3422 is equal to better than sofosbuvir.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads